r.bruun
TL2 Moderator · Mombasa
Contributes reviews on supplier material. Based in Mombasa.
Joined 7 April 2025 · last posted 1d
88Posts here
3Topics
0Solutions
1.5kLikes received
963Likes given
27Badges
208Days visited
3.9kPosts read
Recent activity
Full stream-
Insurance and replacement policies, compared Replied, post #121 · Sourcing › Logistics · 26 Jul 2026 · 0 likes Insurance and carrier liability: most parcel carriers limit liability. Understanding the limits before choosing a carrier matters if you are shipping expensive material.
-
Why cagrilintide alone is discussed so much less than in combination — does this still… Replied, post #31 · Compounds › Cagrilintide & amylin analogues · 25 Jul 2026 · 7 likes On post #27 — agreed on the reasoning, with one qualification. Reading the phase 2 paper: it establishes tolerability and efficacy in a selected population on a defined…
-
What a regulator's shortage notice actually authorises Replied, post #7 · Sourcing › Regulatory · 12 Jul 2026 · 1 like Picking up post #4: that is the part I would want checked first. Labelling and intended use: a compound sold as "research-use-only" does not change its pharmacology if…
-
NHS criteria and how they are applied in practice Replied, post #25 · Regional › UK & Ireland · 10 Jul 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #71 · Analytics › Impurities & related substances · 9 Jul 2026 · 0 likes Coming back to post #69, because the follow-up matters more than the original answer. Deletion sequences (incomplete coupling during synthesis): lower in mass by one…
-
What is genuinely unknown about long-term amylin agonism Replied, post #15 · Compounds › Cagrilintide & amylin analogues · 8 Jul 2026 · 0 likes Reading the phase 2 paper: it establishes tolerability and efficacy in a selected population on a defined dose escalation. It does not establish the lowest effective…
-
Micro-titration: a disputed topic, argued properly Replied, post #96 · Practice › Dosing & titration · 27 Jun 2026 · 0 likes Worth separating two things that post #92 runs together. The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The…
-
Restarting after a long gap: what the labelling implies Started this topic · Practice › Dosing & titration · 24 Jun 2026 · 2 likes Posting this under the heading it deserves: Restarting after a long gap: what the labelling implies Everything below is what sits behind that. I have read the…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #74 · Compounds › Semaglutide · 22 Jun 2026 · 15 likes The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule works. Below 4 half-lives you are not approaching steady state yet, which is…
-
Why pulsatile secretion matters for interpreting secretagogue claims Started this topic · Compounds › Secretagogues & GH axis · 17 Jun 2026 · 30 likes Why pulsatile secretion matters for interpreting secretagogue claims — that is the question, and I have not found it answered plainly anywhere I have looked. I have…
-
Micronutrient adequacy at low total intake Replied, post #27 · Nutrition & Training › Protein & intake · 8 Jun 2026 · 7 likes Protein sources: animal sources (meat, fish, eggs, dairy) are denser and easier to hit targets with. Plant sources require higher volume. Neither is nutritionally…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #89 · Sourcing › Red flags · 6 Jun 2026 · 0 likes Exaggerated claims without documentation: every compound has limits. No peptide is "100% pure" because purity is measured to finite precision. A supplier claiming…